HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideki Kusagaya Selected Research

qing-fei-tang

1/2021[A CASE OF REPEATED DRUG-INDUCED LUNG DISEASES DUE TO MULTIPLE HERBAL MEDICINES CONTAINING COMMON INGREDIENTS].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideki Kusagaya Research Topics

Disease

9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 09/2012
2Neoplasms (Cancer)
01/2022 - 01/2020
2Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 01/2020
2Lung Neoplasms (Lung Cancer)
01/2022 - 01/2019
2Cough
01/2021 - 06/2009
2Dyspnea (Shortness of Breath)
01/2021 - 01/2019
2Lung Diseases (Lung Disease)
01/2021 - 02/2015
2Pneumonia (Pneumonitis)
01/2021 - 10/2009
2Disease Progression
01/2021 - 01/2021
2Vomiting
01/2019 - 12/2015
2Nausea
01/2019 - 12/2015
2Idiopathic Pulmonary Fibrosis
05/2014 - 08/2010
2Fibrosis (Cirrhosis)
12/2012 - 08/2010
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022
1Pneumothorax
01/2021
1Proteinuria
01/2021
1Dermatomyositis (Dermatopolymyositis)
01/2021
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2021
1Fever (Fevers)
01/2021
1Liver Diseases (Liver Disease)
01/2021
1Lung Injury
01/2021
1Lymphocytosis
01/2021
1Sinusitis
01/2021
1Respiratory Insufficiency (Respiratory Failure)
01/2021
1Chronic Obstructive Pulmonary Disease (COPD)
01/2019
1Pneumococcal Infections
02/2015
1Inflammation (Inflammations)
01/2015
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2015
1Asthma (Bronchial Asthma)
01/2015
1Infections
01/2014
1Lymphadenopathy
06/2009
1Pleural Effusion (Pleural Effusions)
06/2009
1Granuloma
06/2009
1Thromboembolism
01/2009

Drug/Important Bio-Agent (IBA)

3NivolumabIBA
01/2022 - 01/2019
3Immune Checkpoint InhibitorsIBA
10/2021 - 01/2019
3Carboplatin (JM8)FDA LinkGeneric
01/2019 - 09/2012
2Bevacizumab (Avastin)FDA Link
01/2021 - 01/2016
2Pharmaceutical PreparationsIBA
01/2021 - 10/2009
2Prednisolone (Predate)FDA LinkGeneric
01/2021 - 06/2009
2AntiemeticsIBA
01/2019 - 12/2015
2Interleukin-17 (Interleukin 17)IBA
01/2015 - 01/2014
1LipidsIBA
01/2022
1CholesterolIBA
01/2022
1Fatty Acids (Saturated Fatty Acids)IBA
01/2022
1Tacrolimus (Prograf)FDA LinkGeneric
01/2021
1sairei-toIBA
01/2021
1saiko-keishi-to (TJ10)IBA
01/2021
1ErbB Receptors (EGF Receptor)IBA
01/2021
1qing-fei-tangIBA
01/2021
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2021
1Plant ExtractsIBA
01/2021
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2020
1B7-H1 AntigenIBA
01/2020
1LigandsIBA
01/2020
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2019
1Olanzapine (Zyprexa)FDA Link
01/2019
1Palonosetron (Aloxi)FDA Link
12/2015
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2015
1Aprepitant (Emend)FDA Link
12/2015
1VaccinesIBA
02/2015
1ImmunosorbentsIBA
02/2015
1Immunosuppressive Agents (Immunosuppressants)IBA
02/2015
1SteroidsIBA
02/2015
1Polysaccharides (Glycans)IBA
02/2015
1EnzymesIBA
02/2015
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2015
1Hematoxylin (Haematoxylon)IBA
05/2014
1Eosine Yellowish-(YS) (Eosin)IBA
05/2014
1CytokinesIBA
01/2014
1CollagenIBA
12/2012
1GemcitabineFDA Link
09/2012
1ChitinasesIBA
08/2010
1Proteins (Proteins, Gene)FDA Link
08/2010
1AcidsIBA
06/2009
1Heparin (Liquaemin)FDA LinkGeneric
01/2009

Therapy/Procedure

5Therapeutics
01/2021 - 09/2012
4Drug Therapy (Chemotherapy)
01/2022 - 12/2015
1Aftercare (After-Treatment)
01/2021
1Immunotherapy
01/2020
1X-Ray Film
06/2009